BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>HWKN benefited from rising specialty chemical prices to reach a new quarterly revenue record for its industrial segment.</li>
<li>The latest quarterly results show the benefits of HWKN’s diversified approach to specialty chemicals. </li>
<li>HWKN reported fiscal Q3 sales of $187.1 million and net income of $10.2 million, or $0.48 per share. We had been forecasting sales to reach $156.8 million in the quarter</li>
</ul>


HWKN benefited from rising specialty chemical prices to reach a new quarterly revenue record for its industrial segment.
The latest quarterly results show the benefits of HWKN’s diversified approach to specialty chemicals. 
HWKN reported fiscal Q3 sales of $187.1 million and net income of $10.2 million, or $0.48 per share. We had been forecasting sales to reach $156.8 million in the quarter


HWKN: Price and Volume Lead to New PT of $52

Hawkins Inc

HWKN: Price and Volume Lead to New PT of $52